Summary
Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a drug development company that develops standard-of-care therapies. The company offers new and small-molecule drugs for regulating the movement of oxygen into tissue. It provides therapeutic for life-threatening diseases. Diffusion develops trans sodium crocetinate, a synthetic small molecule that improves the diffusion of oxygen into hypoxic tissue and sensitizes the tumor to radiation therapy. The company offers products for cancer, stroke and heart attack. It performs clinical study on brain metastasis through cancer centers. Diffusion is headquartered in Charlottesville, Virginia, the US.
Diffusion Pharmaceuticals Inc (DFFN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Diffusion Pharma Raises USD3.4 Million in Venture Financing 11
Diffusion Pharma Raises US$10 Million In Venture Financing 11
Diffusion Pharma Raises US$2.2 Million In Venture Financing 12
Merger 13
RestorGenex Merges with Diffusion Pharma 13
Stratus Media To Merge With Paloma Pharma And VasculoMedics 14
Stratus Media Completes Merger With Canterbury Labs And Hygeia Therapeutics 14
Equity Offering 16
Diffusion Pharma Plans to Raise Funds in Secondary Offering of Shares 16
Diffusion Pharma Raises USD9.2 Million in Second and Final Tranche of Private Placement of Series A Preferred Stock 16
Diffusion Pharmaceuticals Inc - Key Competitors 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
May 15, 2017: Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial First Quarter 2017 Results 22
Mar 31, 2017: Diffusion Pharmaceuticals Provides Corporate Highlights and Reports 2016 Financial Results 23
Nov 14, 2016: Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial Third Quarter 2016 Results 24
Aug 15, 2016: Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial Second Quarter 2016 Results 25
Aug 15, 2016: Diffusion Pharmaceuticals Appoints Biotech Industry Veteran Isaac Blech to Board of Directors 26
May 16, 2016: Diffusion Pharmaceuticals Provides Corporate Highlights and Reports First Quarter 2016 Results 27
Mar 28, 2016: Diffusion Pharmaceuticals Provides Corporate Highlights and Reports 2015 Financial Results 28
Corporate Communications 29
Jul 06, 2017: Diffusion Pharmaceuticals Appoints Dr. Robert Ruffolo to Board of Directors 29
Product News 30
Jul 06, 2016: Diffusion Pharmaceuticals Announces Acceptance of Abstract on Use of TSC in Hypoxia Driven Medical Emergencies at ACEP 2016 Research Forum 30
May 13, 2016: Diffusion Pharmaceuticals Announces Publication of TSC Phase 1/2 Glioblastoma Multiforme Trial Data in the Journal of Neurosurgery 31
Mar 15, 2016: Diffusion Pharmaceuticals Announces Publication of RES-529 Review Article in Anti-Cancer Drugs 32
Clinical Trials 33
Sep 19, 2016: Diffusion Pharmaceuticals Successfully Completes Animal Toxicity Studies in Preparation for Phase 3 Pivotal Trial of TSC in New Diagnosed Glioblastoma Patients 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34
List of Tables
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Diffusion Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Diffusion Pharma Raises USD3.4 Million in Venture Financing 11
Diffusion Pharma Raises US$10 Million In Venture Financing 11
Diffusion Pharma Raises US$2.2 Million In Venture Financing 12
RestorGenex Merges with Diffusion Pharma 13
Stratus Media To Merge With Paloma Pharma And VasculoMedics 14
Stratus Media Completes Merger With Canterbury Labs And Hygeia Therapeutics 14
Diffusion Pharma Plans to Raise Funds in Secondary Offering of Shares 16
Diffusion Pharma Raises USD9.2 Million in Second and Final Tranche of Private Placement of Series A Preferred Stock 16
Diffusion Pharmaceuticals Inc, Key Competitors 19
Diffusion Pharmaceuticals Inc, Key Employees 20
Diffusion Pharmaceuticals Inc, Subsidiaries 21List of Figures
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
